DROZITUMAB
UNII SQ67484MA7

Substance Identification & Data

This profile provides standardized clinical and technical data for Drozitumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SQ67484MA7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 912628-39-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
SQ67484MA7
CAS Registry Number
912628-39-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DROZITUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9255
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
TT-83
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Drozitumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DROZITUMAB

Common Names & Synonyms

ANTI-DR5 RHUMAB-DR5
DROZITUMAB [INN]
DROZITUMAB [USAN]
DROZITUMAB [WHO-DD]
USP MAB 003, MONOCLONAL IGG1 [USP-RS]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CITOKINE RECEPTOR DR5 (DEATH RECEPTOR 5)) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN L3-CHAIN, DIMER

Technical Codes

ANTI-DR5
RHUMAB DR5
RHUMAB-DR5